Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT04656301. We help you review the study, but cannot decide medical eligibility.
CompletedNCT04656301
Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
This study is completed. It focuses on body dysmorphic disorder and currently lists study information in the United States.
Body dysmorphic disorder, Body dysmorphic disorderDrugFrom 18 Years to 55 Years
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 26, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 12
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT04656301
- Official title
- Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
Recruitment & locations
CompletedNew York, United States
Compensation and expense reimbursement have not been verified for this summary.
Registry details
Registry conditions (original wording)
Body Dysmorphic Disorders
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as completed.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT01038128
An Open Label study of Memantine in the Treatment of Eating disorders and Body Dysmorphic Disorder
This study is completed. It focuses on body dysmorphic disorder and currently lists study information in the United States.
CompletedNCT00842309
D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder
This study is completed. It focuses on body dysmorphic disorder and currently lists study information in the United States.
CompletedNCT00149799
Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
This study is completed. It focuses on somatic symptom disorders and currently lists study information in the United States.